Previous studies showed that PRS of AD not only associated with increased risk of AD, but also with neuropathological hallmarks of AD, lifetime risk and the age at onset in both APOE ε4 carriers and non-carriers28,29,51–55. Here, APOE is linked to Alzheimer disease.